亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Comparison of Pharmacokinetics-Pharmacodynamics of Artemisinin Derivatives in Healthy Normal Volunteers and Uncomplicated Malaria Patients

双氢青蒿素 青蒿素 青蒿琥酯 蒿甲醚 药理学 药效学 药代动力学 恶性疟原虫 药品 疟疾 化学 医学 免疫学
作者
Paktiya Teja‐lsavadharm,Supomchai Kongpatanakut,Kesara Na‐Bangchang,Duangsuda Keeratithakul,Maneerat Rasameesoraj,Srivicha Krudsood,Udomsak Silachamroon,S Looareesuwan,Nicholas J. White,Thomas G. Brewer
出处
期刊:วารสารเภสัชวิทยา (Thai Journal of Pharmacology) 卷期号:22: 60-61
摘要

The Artemisinin class of compounds is the most rapidly acting of all antimalarials. Two artemisinin derivatives, artemether and artesunate have been most widely used in the treatment of multi-drug resistant falciparum malaria. Artesunate (AS) and most other artemisinin derivatives (artemether, arteether) are biotransformed to dihydroartemisinin (DHA), the major active metabolite. Dihydroartemisinin is the most potent member of the class in in vitro test system. It is synthesized by chemical reduction of artemisinin extracted from the Chinese herb and is used as the starting material for the manufacture of artesunate, aitemether, and arteether. Since DHA is the most potent and least expensive to manufacture, it has the potential to be developed as an antimalarial drug in the market. Aiiesunate is readily biotransformed to dihydroartemisinin and, therefore, measurement of antimalarial activity in blood provides a critical pharmacodynamics endpoint. Quantitative determination of plasma total antimalarial activity can be performed by the use of an in vitro Plasmodium falciparum bioassay method, which has been validated to measure drug in serum or plasma samples from patients given artemisinin compounds. The plasma antimalarial activity is reported as the concentration equivalent to DHA. In other words, the antimalarial activity of AS is reported as the concentration of DHA that produces the same antimalarial activity as AS. Data from the bioassay provides information on the pharmacokinetic pharmacodynamic or the effect kinetic profile of the drugs. As part of the drug development process, the pharmacokinetic-pharmacodynamic properties of oral dihydroru·temisinin were compared with oral artesunate (4 mg/kg) in a crossover study in Thai healthy volunteers (n=20) and in patients with acute, uncomplicated malaria (n=20) admitted to the Hospital of Tropical diseases, Bangkok. The drugs were given sequentially once daily (day 1 DHA, day 2 AS or vice versa). For patients, mefloquine (MQ) 25 mg/kg was administered as a split dose on the third day to complete the treatment. The maximum effect (Cmax) associated with DHA (1,576 nM) is less than that of AS (4,042 nM) in normal volunteers (p 0.05), there are wide variation in the half-live's associated with AS in patients compared to volunteers (0.5 - 4.0 h). The areas under the effect-time curves corrected for molar dose (AUC/D) of DHA in both volunteers and patients (0.394 and 0.804 h.kg.L - 1 , respectively) are less than AS (0.654 and 1.114 h.kg.L -1 , respectively; p < 0.001). The relative bioavailability of the effect associated with DHA is 70% and 80% of AS in volunteers and patients, respectively. The apparent volume of distribution (Vz/f) of the effect associated with DHA is 2 fold greater than AS (6.8 VS 2.7 L.kg -1 in normal volunteers, p = 0.001; and 2.6 VS 1.6 L.kg -1 in patients, p = 0.005). The clearance (Cl/f) of the DHA effect is faster than that of AS in normal volunteers (3.0 VS 1.7 L.kg -1 .h -1 , p < 0.001) but it is not clinically different in patients (1.3 VS 1.0 L.kg -1 .h -1 , p = 0.01). The volume of distribution and clearance associated with DHA are reduced by half in patients with malaria compared to volunteers (6.79 VS 2.57 L.kg - 1 and 3.03 VS 1.33 L. kg -1 .h -1  , p = 0.001 and < 0.001, respectively). Both parameters for AS are also reduced in patients but to a lesser extent than DHA (2.68 VS 1.59 L.kg·1 and 1.72 VS 1.01L. kg -1 .h -1 , p=0.004 and= 0.006, respectively). In summary, effect kinetic bioavailability of oral DHA is 80% of oral AS in patients. If the production cost of DHA is, in fact significantly less than AS, DHA can be regarded as comparable to or economically better than AS.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ballyhooed完成签到,获得积分10
1秒前
2秒前
嘻嘻哈哈的应助被Minnie采纳,获得10
3秒前
康子浩发布了新的文献求助10
5秒前
英俊大树发布了新的文献求助10
8秒前
暖暖发布了新的文献求助10
8秒前
10秒前
12秒前
12秒前
虚心的迎彤完成签到,获得积分10
12秒前
14秒前
雪山大地发布了新的文献求助10
15秒前
Zhou完成签到 ,获得积分10
15秒前
英俊大树完成签到,获得积分10
15秒前
和谐以冬发布了新的文献求助10
16秒前
研友_VZG7GZ的应助被暖暖采纳,获得10
17秒前
CodeCraft的应助被王艳采纳,获得10
20秒前
histamin完成签到,获得积分10
23秒前
25秒前
28秒前
Collice发布了新的文献求助30
33秒前
杏仁核发布了新的文献求助10
34秒前
充电宝的应助被康子浩采纳,获得10
34秒前
ppp发布了新的文献求助10
35秒前
桃里里完成签到,获得积分10
39秒前
40秒前
42秒前
废纸箱发布了新的文献求助10
45秒前
Minnie完成签到,获得积分10
46秒前
48秒前
杏仁核完成签到,获得积分10
49秒前
沧海君发布了新的文献求助10
51秒前
JamesPei的应助被废纸箱采纳,获得10
51秒前
沉静的愫完成签到,获得积分10
53秒前
康子浩发布了新的文献求助10
53秒前
54秒前
彭于晏的应助被沧海云帆采纳,获得10
57秒前
58秒前
CipherSage的应助被Collice采纳,获得10
1分钟前
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8165884
求助须知:如何正确求助?哪些是违规求助? 9559318
关于积分的说明 21749884
捐赠科研通 7756681
什么是DOI,文献DOI怎么找? 3429083
关于科研通互助平台的介绍 2553367
邀请新用户注册赠送积分活动 2473623